Olema Pharmaceuticals stock jumps 10% into JPM conference week: what OLMA traders are watching next
Olema Pharmaceuticals shares surged nearly 10% Friday to $28.08, outpacing the biotech sector. Investors are watching for updates on its lead breast cancer drug as CEO Sean Bohen prepares to speak at the J.P. Morgan Healthcare Conference on Jan. 13. Board member Ian T. Clark sold all his direct shares last month, SEC filings show.
